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Abstract 
 
Objective: For the establishment of inflammation, a constant interplay between different effector cells from 
circulation, local resident cells, soluble mediators and genetic host factors is required. Molecular mechanisms, 
initiating and perpetuating inflammation, in particular, the involvement of effector cells in redox reactions for 
producing O2- (superoxide anion) through the mediation of NADPH oxidase is a critical step. Prior data suggest that 
reactive oxygen species (ROS) produced by NADPH oxidase homologues in non-phagocytic cells play an important 
role in the regulation of signal transduction, while macrophages use a membrane-associated NADPH oxidase to 
generate an array of oxidizing intermediates which inactivate MMPs on or near them. 
Materials, Methods and Treatment: To clarify the role of NADPH oxidase in T cell-initiated, macrophage-
associated allergic asthma, we induced allergen dependent inflammation in a gp91phox-/- mouse. 
Results: Both inflammation and airway hyperreactivity were more extensive than in wildtype mice post-OVA. 
Although OVA-specific IgE in plasma were comparable in wildtype and knockout mice, enhanced inflammatory 
cell recruitment from circulation and cytokine release in lung and BALf, accompanied by higher airway resistance 
as well as Penh in response to methacholine, indicates a regulatory role for NADPH oxidase in development of 
allergic asthma. While T cell-mediated functions like Th2 cytokine secretion, and proliferation to OVA were up-
regulated synchronous with the overall robustness of the asthma phenotype, macrophage up-regulation in functions 
such as proliferation, mixed lymphocyte reaction, and MCP-1 directed chemotaxis, but downregulation of 
respiratory burst response indicates a forking in their signaling pathways. gp91phox-/- MMP12 double knockout 
(DKO) mice show a similar phenotype as the gp91phox-/- showing the non-involvement or synergistic involvement of 
MMP12 in the response pathway. In mixed lymphocyte reaction using the Increased B7.1 but reduced B7.2 and 
MHC class II expression indicating alteration of co-stimulatory molecule expression critical for T cell activation on 
both gp91phox-/- and DKO mice may explain the mechanism by which gp91phox may regulate Th2 pathway in allergic 
asthma. 
 
 
1. Introduction 
 
Asthma is a complex syndrome with well described 
pathology. However, animal and clinical studies in 
humans continue to provide conflicting data on the 
contribution of local cells viz. airway epithelial, 
endothelial and smooth muscle cells, fibroblasts etc. vs. 
cells recruited from the circulation. Asthma is 
characterized by accumulation of inflammatory cells in 
the lung and airways, secretion of predominantly Th2 
cytokines in the lung and airways, epithelial 
desquamation, goblet cell hyperplasia, mucus 
hypersecretion and thickening of submucosa resulting 
in bronchoconstriction and airway hyperresponsiveness. 
Dysregulated immunity seems to suppress Th1 response 
and triggers Th2 response whose development is 
promoted by antigen presenting cells. Th2 cytokines 
(IL-4, 5, 9, 13) from these cells of which Il-4 and 13 
promote B cell differentiation into plasma cells that 
secrete IgE. Cross-linking of IgE receptors on mast cell 
releases histamines, prostaglandins, thromboxane and 
leukotrienes leading to bronchoconstriction, 
vasodilation and mucus secretion. A cascade of 
interactions between cells and soluble molecules result 
in bronchial mucosal inflammation and lead to airway 
hyperresponsiveness. 
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The production of superoxide anions (O2-) by 
neutrophils and other phagocytes is an important step in 
our body's innate immune response. O2- is the precursor 
of a range of chemicals generally referred to as ROS 
(reactive oxygen species) [1]. These act as microbicidal 
agents and kill invading microorganisms either directly 
or through the activation of proteases [2, 3]. O2- is 
produced by the NADPH oxidase, a multi-protein 
enzyme complex, which is inactive in resting 
phagocytes, but becomes activated after the interaction 
of the phagocyte with pathogens and their subsequent 
engulfment in the phagosome [4]. Defects in the 
function of the NADPH oxidase result in a severe 
immunodeficiency, and individuals suffering from 
CGD (chronic granulomatous disease), a rare genetic 
disorder that is caused by mutations in NADPH oxidase 
genes, are highly susceptible to frequent and often life-
threatening infections by bacteria and fungi [5]. The 
microbicidal activity of ROS has generally been seen as 
the only beneficial function of these chemicals, and 
uncontrolled production of ROS has been implicated in 
tissue destruction and a number of disease states. 
However, over the last couple of years, it has become 
apparent that ROS produced by NADPH oxidase 
homologues in non-phagocytic cells also play an 
important role in the regulation of signal transduction, 
often via modulation of kinase and phosphatase 
activities or through gene transcription [6]. These 
NADPH oxidase homologues are referred to as Nox 
enzymes (gp91phox is specified as Nox2; where phox is 
phagocytic oxidase), and several members of this novel 
protein family have been identified so far. 
There is increasing evidence that redox regulation 
of transcription, particularly activator protein-1 (AP-1) 
and nuclear factor kappa B (NF-B), is important in 
inflammatory diseases.  NADPH oxidase, the primary 
source of reactive oxygen species is a strong candidate 
for the development of therapeutic agents to ameliorate 
inflammation and end-organ damage. The possibility of 
gene therapy for inherited diseases with a single gene 
mutation had been verified by the successful treatment 
with bone marrow transplantation. As the gene therapy 
method and theory have progressed rapidly, it is 
expected that gene therapy will overcome the 
complications of bone marrow transplantation. Of these 
inherited diseases, chronic granulomatous disease 
(CGD) is one of the most expected diseases for gene 
therapy. CGD is an inherited immune deficiency caused 
by mutations in any of the following four phox genes 
encoding subunits of the superoxide-generating 
phagocyte NADPH oxidase. It consists of membranous 
cytochrome b558 composed of gp91phox and p22phox, 
and four cytosolic components, p47phox, p67phox, rac p21 
and p40phox, which translocate to the membrane upon 
activation. The gp91phox subunit (also called the  -
subunit of the cytochrome) consists of 570 amino acids 
and has a molecular mass of 65.3 kDa, but runs as a 
broad smear of approx. 91 kDa on SDS/polyacrylamide 
gels due to a heterogeneous glycosylation pattern of 
three asparagine residues (Asn132, Asn149& Asn240) [7]. 
The N-terminal 300 amino acids are predicted to 
form six transmembrane -helices, while the C-
terminal cytoplasmic domain contains the binding sites 
for FAD and NADPH, shown experimentally through 
cross-linking studies and the observation that 
relipidated flavocytochrome alone can generate O2- []. 
In addition, gp91phox is responsible for complexing the 
two non-identical haem groups of the NADPH oxidase 
via two histidine pairs. Hence gp91phox contains all 
cofactors required for the electron transfer reaction 
which occurs in two steps. First, electrons are 
transferred from NADPH on to FAD and then to the 
haem group in the second step to reduce O2 to O2- in a 
one-electron-transfer reaction. At present, no 
information is available on the three-dimensional 
structure of gp91phox or fragments thereof, although a 
model for the structure of the cytoplasmic domain of 
gp91phox has been suggested based on sequence 
homology with the FNR (ferredoxin–NADP reductase) 
family [High-resolution structure of the nitrile reductase 
QueF combined with molecular simulations provide 
insight into enzyme mechanism [8]. Significant insight 
into the topology of the cytochrome and the sites of 
interaction with other oxidase components has been 
gained through the use of a number of techniques, 
including epitope mapping or random sequence peptide 
phage analysis []. Additionally, the study of 
cytochrome isolated from patients with X-linked CGD 
has contributed to our current understanding of its 
function [9]. 
Involvement of the gp91phox subunit in oxidative 
burst response by PMNs as well as Ms is not clear. 
Macrophages use a membrane-associated NADPH 
oxidase to generate an array of oxidizing intermediates. 
In some studies, it has been demonstrated that oxidants 
potently and efficiently inactivate matrilysin (MMP-7) 
by cross-linking adjacent tryptophan-glycine residues 
within the catalytic domain of the enzyme. These in 
vitro observations suggest that MMP inactivation can 
occur on or near phagocytes that produce both MMPs 
and reactive intermediates. In the absence of reactive 
intermediates, the unrestrained proteolytic activity 
might lead to detrimental tissue damage. Indeed, 
inherited deficiency of gp91phox, a phagocyte-specific 
component of the NADPH oxidase required for oxidant 
production, and targeted deletion of its mouse 
homologue result in granuloma formation and excessive 
tissue destruction [10]. Aberrant regulation of MMP 
activity may contribute to the damage that occurs when 
phagocytes are unable to generate oxidants. gp91phox 
mutant mice were found to develop spontaneously, 
progressive emphysema, equal to that seen in smoke-
exposed wild-type animals. Macrophages and 
neutrophils use membrane-associated NADPH oxidase 
to generate reactive oxygen intermediates. The initial 
product of the NADPH oxidase is superoxide, which is 
converted into oxidizing oxygen and nitrogen species. 
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Because their characteristic end products have been 
detected in diseases ranging from atherosclerosis to 
neurodegenerative disorders, reactive oxygen and 
nitrogen intermediates are thought to contribute to 
inflammatory tissue injury. However, humans and 
animals deficient in phagocyte NADPH oxidase tend to 
form granulomas and to have excessive tissue 
destruction and an exuberant inflammatory response,  
raising the possibility that oxidants derived from white 
cells actually govern or suppress inflammation. 
One potential mechanism whereby reactive oxygen 
species can influence inflammation and the associated 
tissue damage is by regulating the activity of MMPs. In 
addition to their ability to act on extracellular matrix, 
MMPs can affect inflammation by directly or indirectly 
regulating the activity of inflammatory mediators such 
as chemokines. Because reactive intermediates 
effectively inactivate MMPs in vitro, they provide an 
efficient mechanism for inhibiting unregulated catalysis 
by these extracellular proteinases, thereby preventing 
pathological destruction of tissue proteins and 
exuberant inflammation. Production of reactive 
intermediates by the phagocyte NADPH oxidase could 
confine MMP activity in space and time, permitting 
only bursts of pericellular proteolysis. 
This study addresses for the first time the 
relationship between gp91phox and MMP in the 
development of T cell-mediated acute allergic asthma 
in a mouse model using genetic knockout mice,    
gp91phox-/- which will be referred to as NOX-/- and 
MMP12NOX double knockout. The study shows that 
gp91phox most likely has a regulatory role in the onset 
and maintenance of the composite asthma phenotype in 
mouse and deletion of gp91phox may alter expression of 
co-stimulatory/co-inhibitory molecules B7.1 (increased) 
and B7.2 (decreased) and MHCII expression 
(increased) which may explain the mechanism by 
which macrophages despite increased migration to the 
inflammatory foci in vivo and increased migration in a 
chemotaxis chamber to MCP-1, and enhanced 
proliferation to syngeneic or allogeneic stimulus, fail to 
show oxidative burst response. MMP12 seems to be 
either the innocent bystander, not contributing to the 
overall asthma phenotype or has a synergistic (not 
additive) role in the process. 
 
2. Materials and Methods 
 
2.1 Mice 
Both gp91phox–/– mice [11] (Jackson Laboratories, 
Bar Harbor, ME) and mmp12–/– mice were on a 
C57Bl/6J background and had been outcrossed and then 
intercrossed for three generations to generate animals 
deficient in both genes [12]. C57BL6 mice (Taconic) 
were used as the control group and are called wild type. 
In total the following numbers of animals were used in 
each group: 
 
n WT NOX-/- MMP12NOX-/- 
Control (+Alum) 14 14 16 
+OVA 16 15 14 
2.2 Allergen sensitization and challenge 
Mice were sensitized and later challenged with 
OVA (Pierce, Rockford, IL) as described previously 
(2). Mice were immunized with OVA (100g) 
complexed with aluminium sulfate in a 0.2-ml volume, 
administered by i.p. Injection on day 0. On days 8 
(250g of OVA) and on days 15, 18, and 21 (125g of 
OVA), mice were anesthetized briefly with inhalation 
of isoflurane in a standard anesthesia chamber and 
given OVA by intratracheal (i.t.) administration. 
Intratracheal challenges were done as described 
previously (Iwata A, JI, 2001). Mice were anesthetized 
and placed in a supine position on the board. The 
animal’s tongue was extended with lined forceps and 
50l of OVA (in the required concentration) was placed 
at the back of its tongue. The control group received 
normal saline with aluminium sulfate by i.p. route on 
day 0 and 0.05ml of 0.9% saline by i.t. route on days 8, 
15, 18, and 21. 
 
2.3 Pulmonary function tests 
In vivo airway, hyperresponsiveness to 
methacholine was measured 24 hours after the last 
OVA challenge by both invasive and non-invasive 
plethysmography. 
 
2.4 Invasive plethysmography 
On d 22, 24 h after the last intratracheal allergen 
(OVA) challenge invasive pulmonary mechanics were 
measured in mice in response to methacholine in the 
same manner as previously described [13-17] with the 
following modifications:  
a)  The thorax was not opened,  
b)  Mice were ventilated with a tidal volume of 200µl 
and respiratory rate of 120 breaths/min using a 
MiniVent Ventilator for Mice (Harvard Apparatus, 
Holliston, MA),  
c) Mice received aerosolized solutions of methacholine 
(0, 3.125, 6.25, 12.5, 25, 50, and 100mg/ml in 
normal saline) via an AER 1021 nebulizer aerosol 
system (Buxco Electronics, Inc., Wilmington, NC) 
with 2.5-4 micron aerosol particle size generated by 
NEB0126 nebulizer head (Nektar Therapeutics, San 
Carlos, CA), and  
d) A commercial plethysmography system (Model 
PLY4111 plethysmograph, MAX II amplifier and 
pressure transducer system, and Biosystem XA 
software, Buxco Electronics, Inc.) was used to 
determine RL as calculated from measures of 
pressure and flow and expressed as cmH2O/ml/s).  
Non-invasive plethysmography (expressed as Penh) 
was also assessed on d 22 in independent 
experiments. 
 
 
2.5 Noninvasive whole body plethysmography 
In conscious, freely moving, spontaneously 
breathing mice using whole-body plethysmography 
(model PLY 3211; Buxco Electronics, Sharon, CT) as 
previously described (Henderson, W.R., 2005, J. 
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Allergy Clin. Immunol.). Mice were challenged with 
aerosolized saline or increasing doses of methacholine 
(5, 20, and 40mg/ml) generated by an ultrasonic 
nebulizer (DeVilbiss Health Care, Somerset, PA) for 2 
min. The degree of bronchoconstriction was expressed 
as enhanced pause (Penh), a calculated dimensionless 
value, which correlates with the measurement of airway 
resistance, impedance, and intrapleural pressure in the 
same mouse. Penh readings were taken and averaged for 
4 min after each nebulization challenge. Penh was 
calculated as follows: Penh=[(Te/Tr-1)X (PEF/PIF), 
where Te is expiration time, Tr is relaxation time, PEF 
is peak expiratory flow, and PIF is peak inspiratory 
flow X 0.67 coefficient. The time for the box pressure 
to change from a maximum to a user-defined 
percentage of the maximum represents the relaxation 
time. The Tr measurement begins at the maximum box 
pressure and ends at 40%. 
 
2.6 BAL 
After pulmonary function testing, the mouse 
underwent exsanguination by intraorbital arterial 
bleeding and then BAL (0.4ml three times) of both 
lungs. Total BAL fluid cells were counted from a 50l 
aliquot and the remaining fluid was centrifuged at 200g 
for 10 min at 40C and the supernatants stored at –700C 
for assay of BAL cytokines later. The cell pellets were 
resuspended in FCS and smears were made on glass 
slides. The cells, after air drying, were stained with 
Wright-Giemsa (Biochemical Sciences Inc, 
Swedesboro, NJ) and their differential count was taken 
under a light microscope at 40X magnification. Cell 
number refers to that obtained from lavage of both 
lungs/mouse. 
 
2.7 Lung parenchyma 
Lung mincing and digestion was performed after 
lavage as described previously (Labarge S. et al.,) with 
100u/ml collagenase for 1 hour at 370C, and filtered 
through a 60# sieve (Sigma). All numbers mentioned in 
this paper refer to cells obtained from one lung/mouse. 
 
2.8 Lung histology 
Lungs of other animals of the same group were 
fixed in 4% paraformaldehyde overnight at 40C. The 
tissues were embedded in paraffin and cut into 5m 
sections. A minimum of 15 fields was examined by 
light microscopy. The intensity of cellular infiltration 
around pulmonary blood vessels was assessed by 
Hematoxylin and Eosin staining. Airway mucus was 
identified by staining with Alcian blue and Periodic 
Acid Schiff staining as described previously [13-17]. 
 
2.9 Fluorescein-activated cell sorter (FACS) 
analysis 
Cells from hemolysed peripheral blood (PB), bone 
marrow (BM), bronchoalveolar lavage (BAL), lung 
parenchyma (LP), spleen, mesenteric lymph nodes 
(MLN), cervical lymph nodes (CLN), axillary lymph 
nodes (LNX) and inguinal lymph nodes (LNI) were 
analyzed on a FACSCalibur (BD Immunocytometry 
Systems, San Jose, CA) by using the CELLQuest 
program. Staining was performed by using antibodies 
conjugated to fluorescein isothiocyanate (FITC), 
phycoerythrin (PE), allophycocyanin (APC), Peridinin 
Chlorophyll Protein (Per CP-Cy5.5) and Cy-chrome 
(PE-Cy5 and PE-Cy7). The following BD Pharmingen 
(San Diego, CA) antibodies were used for cell surface 
staining: APC-conjugated CD45 (30F-11), FITC-
conjugated CD3 (145-2C11), PE-Cy5 conjugated CD4 
(RM4-5), PE-conjugated CD45RC (DNL-1.9), APC-
conjugated CD8 (53-6.7), PE-Cy5 conjugated B220 
(RA3-6B2), FITC-conjugated IgM, PE-conjugated 
CD19 (ID3), PE-conjugated CD21 (7G6), FITC-
conjugated CD23 (B3B4), APC-conjugated GR-1 
(RB6-8C5), and PE-conjugated Mac1 (M1/70). PE-Cy5 
conjugated F4/80 (Cl:A3-1(F4/80)) was obtained from 
Serotec Ltd., Oxford, UK. PE-conjugated anti-4 
integrin (PS2) and anti-VCAM-1(M/K-2) was from 
Southern Biotechnology, Birmingham, Ala. Irrelevant 
isotype-matched antibodies were used as controls. 
 
2.10 CFU-c assay 
To quantitate committed progenitors of all 
lineages, CFU-c assays were performed using 
methylcellulose semisolid media (Stemgenix, Amherst, 
N.Y.) supplemented with an additional 50ng of stem 
cell factor (Peprotech, Rocky Hill, N.J.) per ml. Next, 
50,000 cells from bone marrow, 500,000 cells from 
spleen, 0.01 million cells from lung and BAL, and 10l 
peripheral blood were plated on duplicate 35-mm 
culture dishes and then incubated at 37°C in a 5% CO2-
95% air mixture in a humidified chamber for 7 days. 
Colonies generated by that time were counted by using 
a dissecting microscope, and all colony types (i.e., burst 
forming units-erythroid [BFU-e], CFU-granulocyte-
macrophage [CFU-GM], and CFU-mixed [CFU-
GEMM]) were pooled and reported as total CFU-C. 
Total CFU-c per organ was calculated by extrapolating 
CFU-c against a number of plated cells to the total 
number of cells in the organ. 
 
2.11 ELISA for cytokines 
Th2 cytokines (IL-4 and 5) and TNF and IFN 
in BAL and serum (previously frozen at –800C) were 
outsourced to Lincoplex Biomarker Immunoassays, 
Millipore. IL-13 was measured by Quantikine M kits 
from R&D Systems, Minneapolis, MN. 
 
2.12 OVA-specific IgE and IgG1 in serum 
Anti-mouse IgE (R35-72) and IgG1 (A85-1) from 
BD Biosciences, San Diego, CA were used for 
measuring OVA-specific IgE and IgG1 (in serum 
previously frozen at –700C) respectively by standard 
ELISA procedures as previously described [17]. 
 
2.13 Chemotaxis assay 
Chemotaxis assay was performed with 10 million 
macrophages pooled from 4 mice/experimental group. 
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Macrophages were prepared by adhering BALf cells in 
high glucose medium for 2 hours followed by 
detachment by mechanical scraping and resuspension in 
Phenol red-free high glucose DMEM (Gibco) with 5% 
FBS with 0.5g/ml Calcein-AM (1:2000 dilution) and 
incubation for 20 min at 370C. MCP-1 at dilutions 
ranging from 0.1-25mM was used and 15mM was taken 
to be the optimum dose. 96 well Neuroprobe CTX 
plates (Chemicon, Temecula< CA) were used. 29l 
MCP-1 (15mM) was added as a single convex drop and 
the polycarbonate filter placed gently over it and 
incubated at 370C for 30 min. The cell suspension was 
added in designated slots over the filter membrane also 
in 29l volume. The chamber was incubated at 370C in 
a humidified CO2 incubator for 2h. Excess cells were 
wiped off with kimwipes at the end of the incubation 
period. Migrated cells were quantified by fluorescence 
(excitation at 488nm, emission at 520nm) using a 
Victor 3V (Perkin Elmer laboratories) using a 
Wallac1420 software. 
 
2.14 Mouse model of pulmonary fibrosis 
A single intratracheal dose of 0.075U/ml of 
bleomycin in 40l saline was administered (d 0), and 
mice were sacrificed 14 and 21d later. Mice C57Bl/6 
were kept under ABSL-2 conditions approved by the 
IACUC of the University of Washington and monitored 
daily. They were housed under specific pathogen-free 
condition and were given food and water ad libitum. 
They were sacrificed on d 14. 1 week after bleomycin 
administration, mice developed marked interstitial and 
alveolar fibrosis, detected in lung sections by Masson’s 
trichrome stain. Analysis of cell populations by 
enzymatic digestion by collagenase Type IV followed 
by cell counting in Coulter counter and subsets 
identified and quantified by FCM and total and 
differential count of H&E stained cytospin smears of 
single cell suspensions show loss of type II and type I 
alveolar epithelial cells and influx of macrophages. AEI 
and II were isolated following standard protocol. 
 
2.15 Real time-PCR analysis 
For real-time PCR analysis of mRNA expression 
of particular genes in differentiating human ESC as 
well as in the lungs of recipient animals in 
transplantation experiments, total RNA was extracted 
from cells (<500/sample) by PicoPure RNA isolation 
kit from Arcturus, Mountainview, CA and those from 
lungs (kept in RNAlater (Ambion) at -800C), by RNA 
extraction kit (RNeasy) from Qiagen and cDNA made 
from it using a Superscript III system from Invitrogen. 
The PCR reaction solution contained 0.5µg of total 
RNA, 6-mM magnesium chloride, and 0.5-µM of each 
primer (primer oligo sequences are in Table 1). Other 
components in the reverse transcriptase–PCR master 
mix included buffer, enzyme, SYBR Green I, and 
deoxyribonucleotide triphosphate. For reverse 
transcription, the 20µL of reaction capillaries were 
incubated at 500C for 2 min followed by a denaturation 
at 950C for 10 min. Polymerase chain reaction by an 
initial denaturation at 950C for 15 s and then annealing 
at 600C 1 min, repeat 45 cycles. Finally, a melting 
curve analysis was performed by following the final 
cycle with incubation at 950C for 15 s, at 600C for 15 s, 
then 950C for 15 s. Negative control samples for the 
reverse transcriptase–PCR analysis, which contained all 
reaction components except RNA, were performed 
simultaneously to determine when the nonspecific 
exponential amplification cycle number was reached. 
Forward and reverse primers are as in Table 1and were 
synthesized by the University of Washington 
Biochemistry services using the Primer Express 
software. PCR was carried out using the comparative Ct 
method (Applied Biosystems software) with SYBR 
Green PCR core reagents (Applied Biosystems) and 
analysed using Applied Biosystems 7900HT Real-Time 
PCR System software SDS 2.2.1. 
 
Table 1. List of mouse primers for real-time PCR.  
 
Cell marker Gene Forward primer Reverse primer 
House-keeping genes GAPDH CGTCCCGTAGACAAAATGGT TCAATGAAGGGGTCGTTGAT 
-actin GTGGGCCGCTCTAGGCACCAA CTCTTTGATGTCACGCACGATTTC 
Cytokine genes 
IFN- GCGTCATTGAATCACACCTG TGAGCTCATTGAATGCTTGG 
IL-1 TCAAGATGGCCAAAGTTCCT TGCAAGTCTCATGAAGTGAGC 
IL-1 TGAAGCAGCTATGGCAACTG GGGTCCGTCAACTTCAAAGA 
IL-2 AACCTGAAACTCCCCAGGAT CGCAGAGGTCCAAGTTCATC 
IL-3 CCGTTTAACCAGAACGTTGAA CCACGAATTTGGACAGGTTT 
IL-4 GGCATTTTGAACGAGGTCAC AAATATGCGAAGCACCTTGG 
IL-5 ATGGAGATTCCCATGAGCAC AGCCCCTGAAAGATTTCTCC 
IL-6 AACGATGATGCACTTGCAGA GGTACTCCAGAAGACCAGAGGA 
IL-10 TGAATTCCCTGGGTGAGAAG TGGCCTTGTAGACACCTTGG 
IL-12 ATCGTTTTGCTGGTGTCTCC CATCTTCTTCAGGCGTGTCA 
IL-13 CCTCTGACCCTTAAGGAGCTT ATGTTGGTCAGGGAATCCAG 
MCP-3 TCTGTGCCTGCTGCTCATAG CTTTGGAGTTGGGGTTTTCA 
Growth factor genes 
TGF2 GGAGGTTTATAAAATCGACATGC GGCATATGTAGAGGTGCCATC 
VEGFa TACCTCCACCATGCCAAG TGGTAGACATCCATGAACTTGA 
VEGFb GGCTTAGAGCTCAACCCAGA TGGAAAGCAGCTTGTCACTTT 
VEGFc GGGAAGAAGTTCCACCATCA TCGCACACGGTCTTCTGTAA 
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Table 2A. Leukocyte subsets (x106) in blood, lungs and BAL fluid post OVA treatment. 
 
Blood 
 Total 
WBCs 
Lymphocytes Monocytes Neutrophils Eosinophils Basophils  
CD3+ B220+      
WA 11.9±2.4 5.54±1.17 3.08±1.05 0.38±0.185 3.648±0.184 0.223±0.014 0.066±0.001  
WO 24.72±6.41 7.31±1.31 5.93±1.17 1.62±0.35 7.97±1.14 0.74±0.36 1.05±0.02  
NOXA 14.2±3.012 5.7±1.865 2.99±1.033 0.77±0.053 4.56±1.074 0.133±0.043 0.028±0.002  
NOXO 25.625±4.063 6.186±1.076 6.742±0.964 2.424±1.076 8.741±0.064 1.061*±0.004 0.556±0.003  
DKOA 11.7±2.76 4.69±1.06 2.467±0.96 0.63±0.12 3.74±1.27 0.106±0.07 0.02±0.001  
DKOO 27.56±2.79 6.61±1.49 7.27±2.01 2.6±0.47 9.39±2.44 1.14*±0.46 0.59±0.14  
Lungs 
 Total 
WBCs 
Lymphocytes Monocytes Neutrophils Eosinophils Basophils/ M 
CD3+ B220+    Mast cells  
WA 1.86±0.543 0.179±0.021 0.035±0.002 0.826±0.054 0.319±0.054 0 0 0.497±0.015 
WO 12.35±3.96 4.87±1.05 0.09±0.01 0.37±0.09 1.47±0.43 2.22±0.76 0.046±0.012 3.09±1.08 
NOXA 5.49#±1.064 0.446#±0.002 0.113#±0.001 2.593#±0.76 0.892#±0.011 0 0 1.489#±0.016 
NOXO 22.6*±7.544 4.084±1.075 1.29*±0.643 3.171*±1.075 4.337*±1.074 4.102*±1.066 0.089*±0.002 5.682±0.064 
DKOA 3.78#±1.07 0.3±0.14 0.07±0.01 1.78#±0.54 0.61±0.02 0.001±0.0001 0 1.02#±0.29 
DKOO 21.66*408 3.891.06 0.43*0.16 3.03*0.89 4.16*1.33 3.93*1.13 0.08 *0.002 5.44*1.26 
BAL fluid (2 lungs) 
WA 0.8±0.013 0 0 0.013±0.004 0 0 0 0.787±0.011 
WO 9.46±0.89 1.64±0.21 1.54±0.021 1.26±0.03 0.86±0.01 4.26±0.07 0.04±0.002 0.56±0.004 
NOXA 0.63±0.018 0 0 0.014±0.002 0 0 0 0.616±0.003 
NOXO 16*±3.159 2.04±0.754 1.213±0.003 2.08±0.074 2.427*±1.066 6.741*±2.076 0.051±0.001 1.568*±0.72 
DKOA 0.865±0.01 0 0 0.025±0.002 0 0 0 0.84±0.18 
DKOO 15.89*±4.03 2±0.86 1.22±0.66 2.05±0.75 2.415*±1.01 6.67*±1.14 0.05±0.003 1.55*±0.63 
Number of cells (x106) of leukocyte subsets in peripheral blood, lung parenchyma and bronchoalveolar lavage fluid (BALf).Total white blood cells were counted by a 
Beckman Coulter particle counter and subsets quantified using specific antibody staining in FACS and corroborated by morphological assessment by light 
microscopy and also by hemavet using the specifics of mouse. The table shows data averaged from three independent experiments  SEM. * denotes p value<0.05 
compared to values from post-OVA wildtype mice and # denotes p value<0.05 compared to alum-treated wildtype. Abbreviations used are: WA=wildtype +alum, 
WO= wildtype + OVA, NOXA=gp91phox-/- + alum, NOXO=gp91phox-/- + OVA, DKOA= MMP12-gp91phox double knockout + alum, DKOO= MMP12-gp91phox double 
knockout + OVA. (n=5/group). 
 
Table 2B. Recruitment index: Inflammatory hematopoietic cells found in lungs and BALf expressed as a fraction of corresponding cells in 
circulation.  
 
  T cells B cells Monocytes Neutrophils Eosinophils Basophils 
Lungs 
WO 0.6 0.015 0.22 0.18 3 0.04 
NOXO 0.6 0.19 1.3 0.49 3.8 0.16 
DKOO 0.58 0.05 1.1 0.44 3.4 0.13 
BALf 
WO 0.22 0.25 0.77 0.107 5.75 0.03 
NOXO 0.32 0.17 0.85 0.27 6.3 0.09 
DKOO 0.51 0.16 0.78 0.26 5.8 0.08 
Number of cells (x106) in lungs and BALf were the numerator and the number of cells (x106) in circulating blood was the denominator in the fraction calculated to 
show recruitment index or inflammatory cells recruited from circulation to lung parenchyma and airways in response to the OVA-allergic challenge. 
 
2.16 Statistical analysis 
Statistical differences among samples were tested 
by Student t test. A P value less than 0.05 was 
considered statistically significant. 
 
3. Results 
 
3.1 The effect of gp91phox deletion on the 
development of composite asthma phenotype 
Composite asthma phenotype developed 
completely and more aggressively in both gp91phox-/- 
and MMP12-gp91phox double knockout mice post OVA 
treatment as described in Fig. 1. Inflammation in terms 
of total inflammatory migration (measured by FACS of 
surface marker expression and differential count of 
H&E stained cytospin smears) was increased (Table 
2A). In bone marrow, NOX-/- post OVA has 1.4-fold 
more cells, in peripheral blood, 1.3-fold more cells, 
spleen had 1.3-fold more cells, lung parenchyma had 
1.8-fold more cells, and BALf: 2-fold more cells 
compared to post-OVA WT. Of note, 2.4-fold more 
PMNs, 1.96-fold more B lymphocytes, 5-fold more 
eosinophils in post-OVA NOX-/- compared to post-
OVA WT BALf was found. Overall systemic response, 
inflammatory recruitment from blood to inflammation 
in the lung is more (Table 2B). 
 
 
 
Fig. 1. Study design to generate an acute allergic asthma phenotype 
in mice: Mice were sensitized with OVA (100g) complexed with 
aluminium sulfate in a 0.2-ml volume, administered by i.p. injection 
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on day 0 and later challenged with OVA On days 8 (250g of OVA) 
and on days 15, 18, and 21 (125g of OVA), (Pierce, Rockford, IL) by 
intratracheal instillation. Mice were immunized with OVA (100g) 
complexed with aluminium sulfate in a 0.2-ml volume, administered 
by i.p. injection on day 0. The control group received normal saline 
with aluminium sulfate by i.p. route on day 0 and 0.05ml of 0.9% 
saline by i.t. route on days 8, 15, 18, and 21. They were sacrificed on 
d22. The abbreviations used are i.p. intraperitoneal; i.t. 
intratracheal; BAL, bronchoalveolar lavage; PB, peripheral blood. 
 
3.2 Pulmonary function test 
Pulmonary function tests measured by both non-
invasive plethysmography and invasive 
plethysmography (Fig. 2A-C) show 2.5-fold increase in 
Penh values compared to WT post-OVA at 100mg/ml 
dose of methacholine. 1.89 and 1.35-folds increase was 
found in gp91phox-/- and DKO respectively at 100mg/ml 
dose of methacholine compared to WT post-OVA by 
invasive plethysmography of anesthetized mice. 
 
 
 
 
 
Fig. 2. Pulmonary function testing. A. Airway resistance in WT vs. 
gp91phox-/-.  
B. Airway resistance obtained by invasive plethysmography show 
increased values in both gp91phox-/- and gp91phoxMM12 double 
knockout mice compared to wildtype post-OVA.  
 On d 22, 24 h after the last intratracheal allergen (OVA) challenge 
invasive pulmonary mechanics were measured using a commercial 
plethysmography system (Model PLY4111 plethysmograph, MAX II 
amplifier and pressure transducer system, and Biosystem XA 
software, Buxco Electronics, Inc.) mice receiving aerosolized 
solutions of methacholine (0, 3.125, 6.25, 12.5, 25, 50, and 
100mg/ml in normal saline) via an AER 1021 nebulizer aerosol 
system (Buxco Electronics, Inc., Wilmington, NC) with 2.5-4 micron 
aerosol particle size generated by NEB0126 nebulizer head (Nektar 
Therapeutics, San Carlos, CA), and RL as calculated from measures of 
pressure and flow and expressed as cmH2O/ml/s was determined. 
Figures show Airway resistance (RL) values  SEM of data obtained 
from 3 independent experiments (n=5/group).   
C. Non-invasive plethysmography (expressed as Penh) was also 
assessed on d 22 in independent experiments with gp91phox-/- only 
and this co-related with the airway resistance values obtained by 
invasive plethysmography.  
For non-invasive plethysmography, mice were challenged with 
increasing doses of aerosolized methacholine (0, 5, and 20, 40, and 
100mg/ml in normal saline) generated by an ultrasonic nebulizer 
(DeVilbiss Health Care, Inc., Somerset, PA) for 2 min. and the degree 
of bronchoconstriction was expressed as enhanced pause (Penh), a 
calculated dimensionless value that correlates with measurement of 
airway resistance, impedance, and intrapleural pressure. Penh is 
primarily independent of FRC, tidal volume, and respiratory rate 
since the ratio of measurements is obtained during the same breath 
and has a strong correlation with both airway resistance (Raw) 
measured directly in anesthetized, tracheotomized, and 
mechanically ventilated mice. *denotes p value<0.01 compared to 
post-OVA wildtype values. 
 
3.3 Cellularity in bone marrow, blood, lungs and 
airways 
Cellularity was increased in post-OVA mice 
compared to saline-treated mice. Fig. 3 shows 1.8-fold 
and 1.7-fold increase in the number of cells in lung 
parenchyma and BALF and 1.4-fold in spleen in both 
KO mice than WT. Recruitment index (Table 2) was 
increased in B cells, monocytes, PMNs, eosinophils and 
basophils in both KO mice post-OVA compared to 
post-OVA WT. 
 
 
 
Fig. 3. Increase in total cell number in the lung and BALf of 
knockout mice compared to post-OVA WT. Cell number was 
counted using a Z1 particle counter from Beckman Coulter. Bone 
marrow cells (BM) were flushed out of two femurs, blood (PB) was 
obtained by infra-orbital bleeding and extrapolated to a 2ml volume 
as the total volume of blood in a 20gm mouse, from the volume of 
blood actually obtained, perfused lung was minced and digested 
with collagenase IV and single cell suspension made of both lungs, 
and bronchoalveolar lavage fluid (BALf) was obtained from both 
lungs, and the cell numbers counted. The data shown have been 
derived from 3 independent experiments and expressed as mean 
values + SEM. *denotes p value<0.01 compared to post-OVA 
wildtype values. Abbreviations used are: WT=wildtype, 
NOX=gp91phox-/-, DKO=gp91phox-MMP12 double knockout, 
WA=WT+alum, WO=WT+OVA, NOXA=gp91phox-/-+alum, 
NOXO=gp91phox-/-+OVA, DKOA= gp91phox-MMP12 double 
knockout+alum, DKOO= gp91phox-MMP12 double knockout+OVA. 
 
3.4 Progenitors in bone marrow, blood, lungs and 
airways 
Table 3 and Fig. 4 shows decrease in number of 
colonies forming units in post-OVA bone marrow and 
WA 
WO 
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NOXO 
WA 
WO 
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WA 
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WO 
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lung of both KO mice compared to similarly treated 
WT. Progenitor number was however somewhat 
upregulated in both KO groups post-OVA compared to 
Post-OVA WT. 
 
Table 3. Decrease in clonogenic potential in bone marrow and lung 
of both KO mice post-OVA. In gp91phox-/- progenitors in BM 
decrease by 28.8% while in double knockout, it decreases by 27.9% 
compared to the values in WT post-OVA. In the lung, the decrease in 
progenitor number was 1.8-fold and 1.5-fold respectively. Results 
shown are pooled from three independent experiments (n=5/group) 
+ SEM. Abbreviations used are BM, bone marrow; PB, peripheral 
blood, LP, lung parenchyma, BALf, bronchoalveolar lavage fluid. The 
total number of progenitors was extrapolated to the total number 
cells obtained from each tissue. 
 
 
 
 
3.5 Inflammation in the lungs 
Histopathology showed a marked increase in 
peribronchiolar and perivascular infiltration of 
inflammatory cells post-OVA in both KO mice 
compared to control (Fig. 5 A-C). The 
photomicrographs show a marked increase in both 
number of inflammatory cells and mucus secretion in 
the airways. 
 
 
Fig.  4. Clonogenic potential was decreased in the bone marrow and 
lung progenitors of both knockout mice post OVA. 10ml heparinized 
whole peripheral blood (PB) obtained by infra-orbital bleeding of 
anesthetized mouse, 50,000 bone marrow cells (BMC) flushed out of 
the femurs, 1 million lung parenchyma (LP) cells digested by 
collagenase IV, 1 million cells from bronchoalveolar lavage fluid 
(BALf) and 500,000 cells from spleen was plated in 2ml semisolid 
methylcellulose medium and cultured for 7 d for PB, BM and spleen 
and for 14d for LP and BALf. Colony forming units (CFU) was counted 
manually on a Leica DMIL and an Olympus sZX12 inverted 
microscope. Results shown are pooled from three independent 
experiments (n=5/group) + SEM. * denotes p value<0.01 compared 
to post-OVA wildtype values. Abbreviations used are: WT=wildtype, 
NOX=gp91phox-/-, DKO=gp91phox-MMP12 double knockout, 
WA=WT+alum, WO=WT+OVA, NOXA=gp91phox-/-+alum, 
NOXO=gp91phox-/-+OVA, DKOA= gp91phox-MMP12 double 
knockout+alum, DKOO= gp91phox-MMP12 double knockout+OVA. 
 
3.6 Airway goblet cell metaplasia 
1.27-fold and 1.22-fold increase in percent 
metaplastic goblet cells (Fig. 6) was measured by 
counting under light microscope, the blue mucus laden 
cells around airways vs. the pink squamous cells which 
do not show metaplasia. 
 
 
 
Fig. 5. Both knockout mice show increased inflammation and mucus secretion post OVA compared to WT. Paraffin sections of lungs of OVA-
treated mice were stained with A, Hematoxylin and eosin (10X), B. with Masson’s Trichrome stain (20X), and C. Alcian blue counterstained with 
eosin (10X). Sections were viewed with a BX4l Olympus microscope and photomicrographs taken with a Nikon Spot digital camera. 
Inflammatory cell migration was more pronounced around the airways in the OVA-treated knockout mice compared to control.  
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Fig. 6. Increase in percent alcian blue positive cells (goblet cell 
metaplasia) in gp91phox-/- and gp91phox-MMp12 double knockout 
(DKO) post-OVA compared to wildtype (WT) post-OVA. Metaplastic 
goblet cells were counted as the blue cells stained positive by alcian 
blue. Percent metaplastic goblet cells are calculated from the total 
number of cells counted around each airway. Abbreviations used 
are: WT=wildtype, NOX=gp91phox-/-, DKO=gp91phox-MMP12 double 
knockout, WA=WT+alum, WO=WT+OVA, NOXA=gp91phox-/-+alum, 
NOXO=gp91phox-/-+OVA, DKOA= gp91phox-MMP12 double 
knockout+alum, DKOO= gp91phox-MMP12 double knockout+OVA. 
The results shown are pooled from 3 independent experiments. 
Counts were taken and averaged over 10 high power fields. Slides 
were counted on a Spencer AO light microscope at 40X 
magnification. Results are expressed as percent  SEM. n= 5 
animals/group. *denotes a p value<0.01 compared to post-OVA 
wildtype values. 
 
3.7 Th2 cytokine release in airway 
Cytokine concentrations present in the BALf were 
measured by ELISA. Fig. 7 shows 2.75-fold increase in 
IL-13 level in gp91phox-/- mice post-OVA compared to 
WT post-OVA. IL-4 was increased All other Th2 
cytokines showed values similar to post-OVA WT 
BALf. Table 4A shows that actual mRNA upregulation 
was 1.4-fold for IL-4 gene and 1.9-fold for IL-13 genes 
which are Th2 specific. There was also upregulation in 
IL-1, IL-10 and IL-12, the significance of which is 
not clear at this point. Cells secreting these are T cells, 
macs and some epithelial cells. Overall, IL-4: NOX-/- 
post OVA has 1.2-fold more protein and 2-fold more 
mRNA; IL-5: NOX-/- post OVA has 2-fold more 
protein and 2.8-fold more mRNA; IL-13: NOX-/- post 
OVA has 3-fold more protein and 5.6-fold more 
mRNA. Therefore, both by protein concentration and 
mRNA expression, Th2 cytokines show a manifold 
increase in gp91phox-/- post-OVA compared to WT. 
 
 
 
Fig. 7. Cytokine concentration in BALf. The concentration of 
cytokines in BALf was measured by outsourcing to Linco by 
multiplexing technique in a luminometer. Data expressed here are 
mean  SEM. n=5/group. While all other Th2 cytokine levels were 
comparable to WT+OVA, IL-13 concentration was increased 2.7-fold 
over post-OVA WT values. Abbreviations used are: WT=wildtype, 
NOX=gp91phox-/-, DKO=gp91phox-MMP12 double knockout, 
WA=WT+alum, WO=WT+OVA, NOXA=gp91phox-/-+alum, 
NOXO=gp91phox-/-+OVA. 
 
 
 
Data in Table 4a are presented in Graph. 
 
Table 4A. Increase in gene expression of IL-1, IL-10, IL-12 and IL-13. Real-time PCR analysis shows expression of mRNA for the particular 
genes as calculated by relative index of Ct values normalized to GAPDH by real-time PCR. PCR was carried out using the comparative Ct method 
(Applied Biosystems software) with SYBR Green PCR core reagents (Applied Biosystems) and analysed using Applied Biosystems 7900HT Real-
time PCR System software SDS 2.2.1. All primers used were specific to mouse. The graphs in* denote p value<0.01 compared to bleo-treated 
untransplanted group. Mean denotes the average of 2 independent experiments (n=4/group). Underlined numbers denote a mRNA expression 
in relative units normalized to mouse GAPDH that have p value<0.05 compared to wildtype post-OVA. Abbreviations used are: cWT= saline 
treated wildtype, WTO=wildtype post-OVA treatment, CKO=saline treated gp91phox knockout, KOO= CKO=OVA treated gp91phox knockout. 
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Table 4B.  Increase in MCP-3 and VEGFb and decrease in TGF, 
VEGFa and VEGFc in post-OVA gp91phox-/- lung. Real-time PCR data 
shows expression of mRNA for the particular genes as calculated by 
relative index of Ct values normalized to GAPDH by real-time PCR. 
PCR was carried out using the comparative Ct method (Applied 
Biosystems software) with SYBR Green PCR core reagents (Applied 
Biosystems) and analysed using Applied Biosystems 7900HT Real-
time PCR System software SDS 2.2.1. All primers used were specific 
to mouse. The underlined number p value<0.01 compared to OVA-
treated wildtype group. Abbreviations used are: cWT= saline treated 
wildtype, WTO=wildtype post-OVA treatment, CKO=saline treated 
gp91phox knockout, KOO= CKO=OVA treated gp91phox knockout. 
 
 
 
 
 
 
Data in Table 4B are presented in Graph. 
 
3.8 Chemokine and growth factor gene expression 
MCP-3 is a known macrophage chemotactic 
protein. Its gene expression was found to be 
upregulated manifolds both in the saline-treated control 
lung as well as post-OVA. The reason for this may be 
that in the absence of gp91phox, there is spontaneous 
upregulation of the chemokine gene. VEGFb was 
upregulated by 2.2-fold. Surprisingly, there was 
downregulation of TGF which might indicate that in 
keeping with decreased iNOS expression and the 
consequent shift in macrophage phenotype to M1 
(killer) from M2 (healer), TGF expression was also 
downregulated corroborating once again that gp91phox 
may have a regulatory role in the development of Th2 
phenotype and deletion of that disrupts the control or 
moderating effect involving cross-talk between T cells 
and the downstream phagocytes which need NADPH 
enzyme for the respiratory burst response and 
proliferation. Increased chemotaxis to MCP-1 may be 
explained by the increased expression of MCP-3. 
Upregulation of MMP12 in gp91phox-/- both before and 
after OVA may indicate a compensatory mechanism in 
the regulation of Th2 response. 
 
3.9 Expression of Rho kinase and MMPs associated 
with inflammation 
Since this is an inflammatory response to the 
allergen, we hypothesized that other pro-inflammatory 
kinases and proteases may also be intimately involved 
in the pathway. Fig. 8 shows RT-PCR analysis of gene 
expression of Rho kinase, traditionally known to have 
anti-inflammatory functions, to be downregulated and 
so are MMP7, 10 and 28. The metalloproteases are also 
known regulators of inflammation and their down-
regulation again corroborates that deletion of gp91phox 
may have disrupted a control mechanism on the 
development of Th2 mediated inflammation in the lung. 
 
 
 
 
Fig. 8. Downregulation Rho kinase RGS-5 and MMP10 but 
upregulation of MMP9 and MMp28 mRNA post-OVA in KO mice 
compared to WT. Real-time PCR analysis was used to quantitate 
expression of mRNA for the particular genes as calculated by relative 
index of Ct values normalized to GAPDH by real-time PCR. PCR was 
carried out using the comparative Ct method (Applied Biosystems 
software) with SYBR Green PCR core reagents (Applied Biosystems) 
and analysed using Applied Biosystems 7900HT Real-time PCR 
System software SDS 2.2.1. All primers used were specific to mouse.  
*denotes p value<0.01 compared to WT+OVA values. # denotes p 
value<0.01 compared to WT+alum (control baseline values). 
n=5/group pooled from 2 experiments. Expression of the gene of 
interest was expressed in relative values normalized to the values 
obtained for mouse GAPDH. Compared to post-OVA WT values, Rho 
kinase RGS-5 mRNA was decreased 2.3-folds and MMp-10 3-fold, 
while MMP-9 was increased 8-fold and MMP-28 increased 2.3-fold 
(*denotes p value<0.05 compared to post-OVA WT). 
 
3.10 Functionality of B cells 
B cell function was tested by measuring OVA-
specific IgE and IgG1 in post-OVA WT and the two 
KO mice. Fig. 9 shows that the values are comparable. 
 
NADPH Oxidase has a Regulatory Role in Acute Allergic Asthma                    Banerjee and Henderson 
J. Adv. Lab. Res. Biol.                            89 
 
 
Fig. 9. Plasma concentrations of OVA-specific IgE and IgG1 are 
comparable between Wt and KO mice post-OVA.  OVA-specific IgE 
and IgG1 were measured by standard ELISA using a capture and a 
detection antibody for each of the immunoglobulins. Data showed 
represents the mean of values pooled from three independent 
experiments (n=5/group). Abbreviations used are: WT=wildtype, 
NOX=gp91phox-/-, DKO=gp91phox-MMP12 double knockout, 
WO=WT+OVA, NOXO=gp91phox-/-+OVA, DKOO= gp91phox-MMP12 
double knockout+OVA. Levels of OVA-specific cytokines in the alum-
treated corresponding control groups were undetectable. 
 
3.11 Functionality of T cells 
Proliferation of MACS-purified (>86-92%) CD4+ 
and CD8+ splenocytes by MTT incorporation assay and 
OD measurement at 545nm of anti CD3/CD28 (0.01-
1ug/ml) induced proliferation of CD4+ shows an 8.4-
fold increase in post-OVA WT compared to a 7.4-fold 
increase in both KO mice. In CD8+ while post-OVA 
WT increased by 6.4-fold, the KO mice showed 7.9-
fold increase compared to the corresponding saline-
treated mice. With PMA/ionomycin (10ng/ml), CD4+ 
(post-OVA WT was 2.3-fold more than that in NOX-/-) 
while CD8+ was 1.5-fold more in post-OVA WT than 
in either KO mice. Overall, whereas proliferation of 
both T cell subsets to anti CD3/CD28 is comparable, 
response to PMA/ionomycin is somewhat compromised 
in KO post-OVA (Fig. 10A, B). 
 
 
 
Fig. 10. T cells respond similarly to stimuli in Wildtype (WT) and 
knockout (KO) mice. A. Splenocytes from control (saline-treated) 
and OVA-treated mice were made into single cell suspensions in 
DMEM+10% heat-inactivated FCS. 0.1 Million cells were plated per 
well without and with increasing concentrations of anti-CD3 
antibody and a constant concentration of anti-CD28 antibody 
(1g/ml) and cultured for 3 days. B. 1M PMA and 10ng/ml 
ionomycin were used to stimulate splenocytes from the above 
experimental mice and proliferation measured after 3 days. To 
measure proliferation, MTT assay called CellTiter96 (Promega) was 
used. OD 546 nm is directly proportional to the number of cells in 
culture. Abbreviations used are: WT=wildtype, NOX=gp91phox-/-, 
DKO=gp91phox-MMP12 double knockout, WA=WT+alum, 
WO=WT+OVA, NOXA=gp91phox-/-+alum, NOXO=gp91phox-/-+OVA, 
DKOA= gp91phox-MMP12 double knockout+alum, DKOO= gp91phox-
MMP12 double knockout+OVA. The data presented are average of 3 
independent experiments  SEM. (n=5/group). 
 
3.12 Functionality of macrophages 
Macrophages and neutrophils are the ultimate 
downstream cells contributing to the asthma phenotype. 
Their functions are measured by the oxidative burst 
response to PMA and chemotaxis to MCP-1. Fig. 11 
shows drastic downregulation of DHR+ cells by FACS 
gated on both Gr-1+ or F4/80+ populations showing 
either myeloid population to be incapable of showing 
respiratory burst response by generating reactive 
oxygen species by responding to PMA. Fig. 12 
however, surprisingly shows upregulation in both 
gp91phox-/- and DKO alveolar macrophages post-OVA. 
So here is a clear forking of signaling pathways 
regulating proliferation on the one hand, which was 
decreased in the KO mice (to PMA/Ionomycin), 
oxidative burst response which was drastically 
compromised (again to PMA) showing perhaps that the 
Protein kinase C pathway may be dysfunct in the 
absence of gp91phox subunit of NADPH oxidase but 
when it comes to chemotaxis, there may be an 
upregulation of MCP-1 expaling the increase in actively 
migrating cells. 
 
 
Fig. 11.  Myeloid cells in BALf of both KO mice fail to respond to 
PMA. Alveolar leukocytes (0.5 x 106 cells) were stained with F4/80-
Cy-Chrome and Gr1-APC for 30 min on ice, washed in PBS, warmed 
up at 370C for 5 min and loaded with 5mM dihydrorhodamine 123  
(Molecular Probes, Eugene, OR). After 10 min at 370C, cells were 
split into two equal aliquots, and PMA (Sigma, St. Louis, MO) was 
added to one aliquot at a final concentration of 1mM. After 10 min 
incubation cells were washed in ice-cold PBS and immediately 
subjected to FACS analysis. Cells were gated on neutrophils (Gr1hi), 
or monocyte/macrophages (F4/80+) and percentage of cells positive 
for dihydrorhodamine 123 fluorescence with or without PMA 
treatment was determined for each gate. Results shown are mean of 
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3 independent experiments  SEM. (n=5/group). * denotes p 
value<0.05 compared to WT without PMA treatment and # denotes 
p value<0.05 compared to WT post-PMA treatment. While WT cells 
respond to PMA before as well as after OVA challenge, cells from 
both KO mice before as well as after OVA, failed to respond 
appreciably. DHR was measured at Fluorescent channel 1 in using a 
BD FACScalibur and DHR+ cells (CD45+gated and Gr-1+ gated or 
F4/80+ gated) were analyzed using CellQuest Pro software. 
 
3.13 T cell-macrophage crosstalk 
Based on the aforementioned responses of T cells 
and macrophages it seems apparent that both cells are 
able to function well in response to OVA on their own 
at least as far as the asthma phenotype is concerned. 
They migrate in increased numbers from the blood and 
resident as well as recruited cells are found in 
impressive inflammatory exudates around the airways. 
So the next question was whether there is efficient 
cross-talk between the T cells upstream and the 
macrophages downstream. To this end, we did a mixed 
lymphocyte reaction using first the CD4+ T cells as the 
responders and the -irradiated alveolar macrophages as 
the stimulators from the experimental mice themselves 
and then used CD4+ T cells from splenocytes of 
BALB/c mice. Increase in proliferation measured by 
MTT assay (OD 570nm) shows increased T cell: APC 
interaction both when autologous APCs (macrophages 
from the adherent cell population in BALf of the same 
animal) were used and then APCs from experimental 
animals were used as stimulators to CD4+ T cells from 
the spleen of BALB/c mice which were the responders. 
 
 
 
 
Fig. 12. MCP-1-driven chemotaxis of alveolar macrophages was 
increased in both KO mice post-OVA. 15mM MCP-1 was put in 29l 
volume in the lower well and 10x106 alveolar macrophages (from 4 
mice/experimental group), also in 29l volume in the upper wells of 
a 96 well Neuroprobe CTX plates (Chemicon) in high glucose medium 
for 2 h followed by detachment by mechanical scraping and 
resuspension in Phenol red-free high glucose DMEM (Gibco) with 5% 
FBS with 0.5g/ml Calcein-AM (1:2000 dilution) and incubation for 
20 min at 370C. Migrated cells were quantified by fluorescence 
(excitation at 488 nm, emission at 520 nm) using a Victor 3V (Perkin 
Elmer laboratories) using a Wallac 1420 software. 2.5-fold and 1.26-
fold increase in OD (proportionate to number of fluorescing cells in 
the upper well equivalent to the number of cells migrated) was 
found in post-OVA gp91phox-/- and DKO mice respectively. * denotes 
p value<0.05 compared to values in OVA-treated wildtype group. 
 
 
 
Fig. 13. Mixed lymphocyte reaction with CD4+ T cells and antigen 
presenting cells (APC) before and after OVA treatment. 0.1x105 
CD4+ T cells isolated by magnetic activated cell separation (MACS) by 
positive selection from spleen of the mice were co-cultured with -
irradiated 0.1x103 adhering alveolar macrophages from BALf of the 
same experimental animal. Both cell types were from the 
experimental animals themselves viz. C57Bl/6 WT and KO mice. This 
is Syngeneic MLR where the APCs (alveolar macrophages) were -
irradiated (3300rads). Allogeneic MLR reaction involves co-culturing 
0.1x105 CD4+ T cells from the spleen of BALB/c mice with 0.1x103 -
irradiated APCs from BALf of the experimental mice. Both control 
(saline-treated) and OVA-treated of each group were tested. Each 
culture was incubated with 1g/ml OVA. The responders here are 
the T cells and the stimulators are the APCs, viz. alveolar 
macrophages which are -irradiated to inhibit their own 
proliferation. Since acute allergic asthma is a Th2 mediated 
phenomenon, interaction between T cells and macrophages will 
elucidate functional cross-talk between the two cell types when 
responders are autologous as well as when they are from a different 
species. 2-fold increase in post-OVA NOX vs. post-OVA WT and 2.16-
fold increase in post OVA-DKO vs. post-OVA shows that T cell: APC 
interaction is actually more efficient in the absence of the gp91phox 
and MMP12 as well as gp91phox. 
 
3.14 iNOS expression 
iNOS is a surface enzyme expressed by 
macrophages that are of the M1 or killer phenotype. 
Fig. 14 shows decrease in percent iNOS+ cells in PB, 
spleen, lung and BALf but not BM. This may indicate 
that there is a skewing of macrophage phenotype from 
killer to healer phenotype. This corroborates well with 
data in Fig. 11, 12 that these macrophages although 
migrating to the inflammatory focus in increased 
numbers are incapable of typical phagocytic functions 
which indicates a clear dichotomy in their signaling 
pathways. 
 
NADPH Oxidase has a Regulatory Role in Acute Allergic Asthma                    Banerjee and Henderson 
J. Adv. Lab. Res. Biol.                            91 
 
 
 
 
 
 
 
 
 
 
Fig. 14. Decrease in percent iNOS positive cells, as well as total 
number of them in gp91phox-/- (NOX) mice, post OVA compared to 
wildtype (WT) post-OVA. Cells from all tissues viz. BM, PB, Spleen, 
lung and BALf of NOX-/- vs. WT with and without OVA. or we could 
put % and # in tabular form. A1-E1. Percent iNOS positive cells in BM, 
PB, Spleen, LP and BALf respectively. A2-E2. Number of iNOS positive 
cells in BM, PB, Spleen, LP and BALf respectively cells in million. Data 
shows mean of 2 independent experiments which were pooled  
SEM. (* denotes p value<0.05 compared to WO). Abbreviations used 
are: WT=wildtype, NOX=gp91phox-/-, WA=WT+alum, WO=WT+OVA, 
NOXA=gp91phox-/-+alum, NOXO=gp91phox-/-+OVA. 
 
3.15 Expression of co-stimulatory molecules 
We hypothesized that expression of MHC 
molecule, which controls T cell activation by APC may 
be somehow affected in this mechanism. Fig. 15 
indicates a 1.65-fold increase in post-OVA gp91phox-/- 
lung parenchyma cells and a 1.38-fold increase in DKO 
cells in B7.1 positive cells from undetected positive 
cells in saline-treated in any group. B7.2 and MHCII 
expressions were however decreased in both KO mice 
with 3.28-fold and 3.18-fold decrease respectively in 
gp91phox-/- and DKO. MHCII expression was 
downregulated by 1.18 and 1.13-fold in the two KO 
mice respectively. 
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Fig. 15. Increase in B7.1 but decrease in B7.2 and MHCII expression 
in BAL cells. B7.1, B7.2 are co-stimulatory molecules expressed on 
alveolar macrophages and other antigen presentation cells like the 
dendritic cells and also B cells and monocytes. Expression of the said 
molecules was measured by FACS using specific fluorochrome-
conjugated antibodies from Pharmingen. The data presented shows 
percent cells positive for the given antigen, expressed as mean  
SEM. n=4/group. 
 
3.16 Bleomycin-induced fibrosis 
Fig. 16 shows increase in soluble collagen content 
of whole lung in gp91phox-/- but not DKO where values 
were similar to baseline showing that response did not 
occur. Gp91phox-/- lung showed 1.3-folds increase in 
freshly synthesized collagen post-OVA compared to 
post-OVA WT. Histopathological staining with 
trichrome stain showed appreciable collagen deposits in 
WT and gp91phox post OVA but less in DKO lung 
(Panel A). A similar trend was found in picrosirius red 
stain (Panel C). Interestingly TGF staining was 
pronounced around the airways in WT and gp91phox-/- 
post-OVA but not DKO.  
 
 
 
Fig. 16. Increase in collagen content of lung post-bleomycin in 
gp91phox-/- but not in MM12-gp91phox double knockout mice. Total 
collagen content freshly synthesized in the lung was measured by 
Sircol assay. Data represent mean of 2 independent experiments, 
n=4/group. Data are expressed as average  SEM. * indicates the p 
value<0.05 compared to post-OVA value in wildtype mice. 
Abbreviations are: WS= saline-treated wildtype (baseline), 
WB=bleomycin-treated (single intra-tracheal dose of 0.075U/ml 
bleomycin and animals was sacrificed 14 and 21 d later. Here d21 
data are shown), NOXS=saline-treated gp91phox null, 
NOXB=bleomycin-treated gp91phox null, DKOS=saline treated 
MMP12- gp91phox double knockout, DKOB=bleomycin-treated 
MMP12- gp91phox double knockout. 
 
 
 
 
Fig. 17. Increased inflammation and fibrosis in lung of WT and gp91phox-/- mice but not MMP12gp91phox double knockout mice. 21d post-
bleomycin treatment, mice were sacrificed and lungs were fixed overnight in 4% paraformaldehyde and embedded in paraffin. 8 sections 
were stained by dyes (A, C. Masson’s trichrome stain and picrosirius red respectively) and immunostained with TGF antibody and color 
developed by DAB (B). Arrows point at blue collagen deposits in panel A, TGF positive stain in panel B and to red collagen staining in panel C. 
In panel A, pinkish purple stains are that of cytoplasm and blue are the nuclei of inflammatory cells. Light blue stains are of collagenous 
deposits. While WT and gp91phox-/- (designated as NOX-/- show increased collagen deposits and inflammation around airways post-OVA (all 
sections are those of post-OVA lung), MMP-12-gp91phox double knockout lung shows minimum collagen deposition as well as TGF expression. 
While Panel A and B were at 60X magnification, Panel C was at 10X. Panel A inset shows another area of collagen deposition in bleo-treated 
wildtype (WB), NOXB and DKOB are bleo-treated gp01 phox-/- and double knockout respectively. The photomicrographs were taken in an 
Olympus VX4L microscope and Nikon digital camera. All photomicrographs were at 60X magnification. 
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3.17 Cells in BALf and lung post bleomycin over 
time 
Total number of cells and cell subsets were 
measured periodically over time in WT, and the KO 
mice (Table 5A-D). Total cells were increased in 
bleomycin-treated NOX-/- mice at d7 after bleo with 
macrophages and lymphocytes contributing the most of 
the increase. PMNs also increased in percentage but 
total number was comparable to that in post-bleo WT. 
DKO, on the other hand, did not show a very low 
increase in the total number of cells over their saline-
treated control group with lymphocytes and PMNs 
contributing to the slight increase entirely. Compared to 
saline treated WT, number of cells increased 6.6-folds a 
week after bleomycin treatment. This denuded at d14 
and further at d21. So similar to previous data, cell 
number in BALf is actually not an indicator of the 
extent of fibrosis by d21. Similar trends were found in 
the lung (Table 5C). D7 probably signals the onset of 
fibrosis by increased cellular recruitment. Macrophages 
and T cells are the chief secretors of TGF traditionally 
thought to activate the collagen synthesis and 
deposition by alveolar epithelial cells. d8-21, therefore, 
is the scar tissue formation period when AEI has 
become denuded and so have AEII. This is shown in 
Table D where there is a progressive decrease in AEI 
through d21 while AEII first increased slightly only to 
equilibriate at d21. NOX-/- BALf showed a 1.7-fold 
increase in cell number which decreases predictably by 
d21. DKO BALf, however, shows no appreciable 
increase over saline treated either at d7 or at d21. 
Macrophages seem to be the chief cell populations 
accounting for this increase. In lung (Table 5C) 
however, on d7, a similar trend to that in BALf is 
found. The only difference is that both macrophages 
and lymphocytes make up for the increase. 
 
Table 5A-D. Trends in cellular migration to BALf and Lung post-bleomycin over time and number of constitutive cells in lung. A-C represent 
CD45+ hematopoietic cells and D represent data on CD45- cells staining positive for alveolar epithelial cells. A. Number of cells in BALf a week 
after bleomycin treatment, B. Number of cells in BALf before and after bleo challenge where WT mice were assessed at d7, 14, and 21 and KO 
mice were assessed on d7 and d21, C. Number of cells in lung parenchyma (Lp) on d7 in all as no appreciable difference in cell numbers were 
found over time from d7-21, D. Number of cells in BALf of saline-treated and post-bleomycin (d7) wildtype (WT), gp91phox-/- (NOX) and MMP12- 
gp91phox double knockout (DKO) mice were assessed by Z1 Coulter particle counter from Beckman Coulter and differential counts done by 
specific fluorochrome antibody conjugates by FACS and by morphology in the light microscope. The data presented are mean ± SEM of 2 
independent experiments (n=5/group).  
CD45+ cells were gated and macrophages (Gr1-F4/80hi), lymphocytes (CD3+ and B220+), and neutrophils (Gr-1hi F4/80-) were identified, their 
percentages analyzed by CellQuest Pro and their total numbers calculated from the total number of cells obtained by lavage as described in 
materials and methods. The data presented is pooled from 2 independent experiments  SEM. * denotes a p value<0.05 compared to WT post-
bleo on corresponding time points. Abbreviations used are: WS=Wildtype (WT) +saline (d7), WB7= WT+post-bleomycin d7, WB14= WT+post-
bleomycin d14, WB21= WT+post-bleomycin d21, NOXS=gp91phox-/-+saline d21, NOXB21= gp91phox-/-+bleomycin d21, DKOS= gp91phox-MMP12 
double knockout + saline (d21), DKOB21= gp91phox-MMP12 double knockout + bleomycin (d21). 
 
Table 5A. Number of cells in BALf after a week of Bleomycin treatment. 
 
 
Table 5B. Number of CD45+ cells in BALf before and after bleomycin treatment (1 i.t. dose of 0.074 U/ml in 40µl volumes). 
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Table 5C. Number of (CD45+) cells in LP before and after bleo treatment. 
 
 
Table 5D. Number of CD45+ cells counterstained with alveolar epithelial cells before and after bleomycin treatment. 
 
] 
 
 
Fig. 18. Side population cells in lung before and after bleo in WT vs. 
KO mice. Side population cells were flow sorted by Hoechst dye 
effluxing cells from single cell suspension prepared by Dispase 
1.2U/ml digested lung parenchyma incubated with 1:200 from 
Hoechst stock (aliquoted and frozen at - 200C in 370C water bath for 
90 min and then flow sorted on FACSaria gating on a small (0.1%) cell 
population forming the characteristic “shoulder” OF actively dye-
effluxing cells. The figure presents percent SP data in all three 
genotype groups before and after bleo treatment. The data 
presented is pooled from 2 independent experiments ±SEM. * 
denotes a p value<0.05 compared to WT post-bleo on d7. 
Abbreviations used are WS=Wildtype (WT) +saline (d7), 
WT=WT+post-bleomycin d7, NOXS=gp91 phox-/-+saline d7, NOXB= 
gp91 phox-/-+bleomycin d7, DKOS= gp91 phox-MMP12 double knockout 
+ saline (d7), DKOB = gp91 phox-MMP12 double knock out + 
bleomycin (d7). 
 
4. Discussion 
 
Briefly, deletion of gp91phox results in enhancement 
of composite asthma phenotype in mouse. Double 
deletion of gp91phoix and MMp12, a critical enzyme 
for phagocyte associated inflammation results in no 
alteration of the phenotype generated in the single 
deletion of gp91phox-/-. There is a clear dichotomy in the 
macrophage function but overall, T cell function and 
macrophage functions are well coordinated. While 
inflammation in terms of inflammatory cell migration is 
enhanced, macrophage function downstream may not 
be all that bad. If gp91phox is imagined to have a 
regulatory role in the development of the asthma 
phenotype, MMP12 seems to have a similar if not 
synergistic effect. These molecules are however not 
necessary for migration but are critical for PMA 
induced proliferation and MCP-1 induced chemotaxis. 
The overall Th2 response was enhanced possibly due to 
a lack of control over T cell: APC cross-talk in the KO 
mice as shown by MLR. Increased B7.1 but decreased 
B7.2 and MHCII expression may provide possible 
mechanisms for this regulatory function of gp91phox and 
MMP12. On the other hand, in a predominantly 
macrophage perpetrated disease model of bleomycin-
induced pulmonary fibrosis, gp91phox-/- mouse shows 
the same trend of runaway inflammation and the 
resultant fibrosis but not so when MMP12 is deleted 
additionally. This may mean that while deletion of 
gp91phox may abolish the control mechanism required 
for keeping effects of bleomycin under check, 
additional deletion of MMP12 fails to elicit any effect 
of bleomycin after 21 days of treatment when fibrosis is 
fully developed. Therefore MMP12 may be critical for 
phagocytes to process signals necessary for a) increased 
AEI and AEII mortality, b) increased collagen 
synthesis, and c) inflammation, the first step for 
accumulation the cell populations in lung and BALf to 
initiate the onset and development of the fibrotic 
process itself.   
The results described above indicate that    
gp91phox-/- mice respond to OVA in a more exaggerated 
fashion compared to WT post-OVA, in terms of total 
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number of cells migrated to the lung (1.8 folds) and 
BALf (1.7 folds), although the total number of cells in 
bone marrow (obtained from two femurs) and that in 
circulating peripheral blood were comparable. 
Expressed as a fraction of circulating cells recruited 
into the lungs and BALf in response to allergic immune 
response, both knockout mice seem to show similar 
trends. Cell subsets for which recruitment index is more 
than 1, indicate a cumulative effect where both cells 
from circulation as well as resident cells normally 
present in the pulmonary milieu in surveillance, seem to 
be equally important. Recruitment of B cells, 
monocytes, neutrophils and basophils are increased in 
the lungs of both knockout mice compared to post-
OVA wildtype while that of T cells, neutrophils and 
basophils in BALf are increased in the knockout vs. the 
OVA-treated wildtype (Table 2B).  
MMP-9 is known to play a role in the migration 
and inflammatory responses by Eos and PMN, and 
control repair responses in asthma, especially in the 
resolution of allergic inflammation. So upregulation of 
MMP-9 gene in upon gp91phox deletion and also post-
OVA treatment of the knockout mouse, cannot be 
explained easily. It may either have a protective role 
which is confounded upon deletion of gp91phox or it 
may be a compensatory mechanism in reaction to the 
deletion of the same. Any complementary role of this 
metalloprotease with the subunit of NADPH oxidase is 
unknown. MMP-12, on the other hand, controls the 
migration of monocytes and macrophages to 
inflammatory sites and airway remodeling by degrading 
ECM proteins [18]. It is supposed to have a protective 
effect in emphysema [19]. 
B7.1, a co-stimulatory signal necessary for the 
activation of T cells, can be expressed on the cell 
surface by B cells, dendritic cells and macrophages, the 
antigen presenting cells.  It is associated with activation 
of cell-mediated response, especially Th2 response. At 
baseline, they are not expressed but upon activation are 
upregulated. In our model, upregulation of B7.1 but 
downregulation of B7.2 and MHCII shows a possible 
mechanism by which gp91phox and MMP12, may 
synergistically regulate Th2 responsiveness and 
deletion of the same disrupts this pathway. 
Mature T lymphocytes become activated to 
perform their effector functions when stimulated by 
appropriate APC bearing MHC class I or class II 
molecules. They require both antigen-specific and 
immunoregulatory signals for optimum activation. The 
first signal comes from the T cell receptor as it 
recognizes antigenic peptides presented by MHC 
molecules. A variety of co-stimulatory receptors 
provide the second signal when they interact with 
ligands on APCs. The B7 family of ligands and their 
receptors is important in pathways of co-stimulation 
and inhibition if immune responses. B7.1 and B7.2 are 
co-stimulatory molecules capable of turning on the 
immune system by regulating antigen-specific 
activation and proliferation of lymphocytes and play a 
critical role in regulating the immune system. 
Appropriate co-stimulation may alter the number and 
strength of MHC-peptide-TCr complexes necessary for 
T cell activation. It may also complement the 
intracellular signals sent via T cell receptors and help T 
cells adhere to APCs to promote MHC-peptide-TCR 
interaction. These MHC molecules bind TCR and 
simultaneously engage either CD8 or CD4. T cell 
activation and differentiation requires not only TCR 
recognition of the antigen-MHC complex, but also 
costimulation through the interaction of accessory 
molecules on APC and their corresponding receptors on 
T cells. CD28 is an important costimulatory receptor on 
T cells and binds to CD80 (B7-1) and CD86 (B7-2) on 
activated APC [20,21]. The crucial role played by 
CD28 in the proliferation and differentiation of T cells 
has been highlighted by studies using CD28 knockout 
mice. However, some immune responses remain intact 
in the absence of CD28, perhaps because a prolonged 
TCR signal overcomes the need for costimulation, 
and/or other costimulatory molecules can substitute for 
CD28 [22,23]. Additional T cell costimulatory 
molecules, i.e. ICOS, were identified, and have 
functions similar to, but not completely overlapping 
with, CD28. ICOS is not expressed by resting T cells, 
but is induced after T cell activation and is important 
for T cell activation and effector function [24,25]. ICOS 
costimulation failed to significantly up-regulate IL-2; 
however, it up-regulated the secretion of IL-4, IL-5, 
IFN- , TNF-  and GM-CSF to 50-70% of the levels 
achieved with CD28 costimulation [26]. Following 
cellular activation, lymphocytes can differentiate into 
Th1 or Th2 cells according to the type of cytokine they 
produce, the balance of which will ultimately determine 
the outcome of the cellular response. Typically, 
production of IFN-  and IL-12 will favor a Th1 
response, whereas presence of IL-4and IL-10 will 
determine a Th2 pattern. In HP no clear pattern of 
polarization has been defined. In experimental models, 
Th1 responses may be important since Th1 CD4+ cells 
can adoptively transfer the disease to healthy animals 
[26]; IFN-  and IL-12 may also play a role in the 
pathogenesis of HP in mice [27,28], but in human HP, 
recent studies suggest that a Th2-type response is 
predominant [29,30]. T cell activation requires at least 
two distinct signals [31]; the first is Ag-specific and is 
delivered through the engagement of TCRs. The second 
signal is mediated by the interaction of costimulatory 
molecules present on APCs with their ligands on T 
cells. The B7:CD28/CTLA4 is a major pathway which 
provides these potent signals, crucial for complete T 
cell activation. CD28 and CTLA4 are ligands for B7-1 
and B7-2. These ligands bind to both B7 but with 
different avidities, CTLA4 binding is 20-to 100-fold 
higher than CD28. This difference in avidity has been 
exploited to block B7-CD28 interactions by the use of 
CTLA4-Ig, a soluble fusion protein made from the 
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extracellular portion of CTLA4 linked to the Fc portion 
of IgG [32]. Furthermore, B7/CD28 costimulatory 
pathway may influence not only the extent of T cell 
activation but also the regulation of T cell 
differentiation [33]. Depending on the system studied, 
B7 costimulation has been shown to influence both Th1 
and Th2 cytokine production [34]. In the normal lung, 
alveolar macrophages (AM) have a low expression of 
B7 molecules and a poor capacity to function as APCs 
[35]. So antagonistic alterations in B7 family of 
receptors in the acute asthma pathway may indicate a 
definite role for either gp91phox or both gp91phox and 
MMP12 in controlling the co-stimulatory activating 
pathway in T cell activation in Th2 response. The role 
of MMP12 and gp91phox are however probably 
completely different in bleomycin-induced fibrosis and 
need further study. 
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